Prebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease Patients

<p>The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.</p>